유럽, 중동 및 아프리카(EMEA)의 바이오 농약 종자 처리 : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the Europe, Middle East, and Africa (EMEA) biopesticides seed treatment market size was valued at USD 1.28 billion in 2025 and is projected to reach USD 1.44 billion in 2026 and USD 2.69 billion by 2031, growing at a CAGR of 13.31% from 2026 to 2031.

Europe, Middle East, and Africa (EMEA) Biopesticides Seed Treatment Market Trends and Insights

Rising Demand for Low-Residue Crop Protection

Export-oriented farm systems are reshaping input decisions across the EMEA biopesticides seed treatment market. Buyers supplying European food chains continue to prioritize strict residue compliance, increasingly influencing seed treatment decisions before planting begins. This trend is particularly relevant in crop systems where growers seek to reduce later-stage chemical applications and start the season with cleaner, more sustainable crop protection programs. Policy direction continues to reinforce this transition, with regulatory strategies focusing on reducing reliance on conventional chemical pesticides and promoting safer alternatives. The Farm to Fork Strategy remains central to this shift, targeting a 50% reduction in chemical pesticide use and risk by 2030 in the European Union. Recent policy developments also support the faster adoption of biocontrol solutions by creating a more favorable regulatory pathway for biological crop protection products. In the market, these developments strengthen the commercial case for microbial and biological seed treatments that align agronomic practices with residue-sensitive trade requirements. They also expand the overall addressable demand base, as adoption increasingly extends beyond certified organic production into mainstream commercial agriculture.

Expansion of Biologicals in Seed Coating Workflows

The EMEA biopesticides seed treatment market is gaining momentum as biological actives are increasingly incorporated into standard seed-coating workflows rather than remaining limited to niche trial programs. Once a seed company integrates a biological treatment into its routine coating process, adoption becomes more consistent and less dependent on farm-level handling. This transition is strengthening the commercial case for biologicals by improving scalability and operational efficiency. BASF SE states that Integral Pro, which is based on Bacillus amyloliquefaciens MBI600, has protected millions of hectares of oilseed rape in Europe. The company received its first sunflower registration in France in November 2025, with European Union (EU)-wide availability planned for the 2026 sowing season. At the same time, the shift toward advanced coating systems is increasing the importance of formulation compatibility and process integration. As a result, the market is becoming more closely linked to formulation expertise and coating performance rather than the simple availability of active ingredients. This dynamic favors suppliers that can align biological efficacy with the physical and operational requirements of industrial seed processing.

Variable Field Efficacy Across Soil And Climate Conditions

Variable performance across soil and climate conditions remains a major constraint on the market. Biological activity during the short window between sowing and crop establishment depends heavily on soil temperature, moisture, pH, and the local microbial community. These conditions vary considerably across EMEA, particularly between temperate Europe and hot, arid production zones. A 2026 study in Plants evaluated bacterial biocontrol agents against olive mite pests under Saudi Arabian conditions, highlighting the importance of locally tested biological solutions for climate- and pest-specific applications. In the EMEA biopesticides seed treatment market, a single poor field result can have an outsized effect, as growers often rely on peer observation before adopting a new treatment approach. This makes locally generated trial data more important than efficacy claims from other geographies. Until suppliers build broader validation across hot and moisture-stressed cropping systems, climate-linked performance variability will continue to restrain adoption.

Other drivers and restraints analyzed in the detailed report include:

1. Grower Adoption of Preventive, Early-Season Crop Protection
2. Regulatory Pressure on Synthetic Seed Treatments
3. Limited Shelf Life And Storage Sensitivity Of Biologicals

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Insecticides accounted for 44.0% of the EMEA biopesticides seed treatment market share in 2025, making them the largest product type in the current mix. This leadership reflects the continued need for early-season pest protection in cereals, maize, sugar beet, and oilseed systems across Western and Central Europe. The gradual reduction in availability of certain synthetic seed treatment options has increased the relevance of biological insect control alternatives in these crop systems. As a result, the market continues to rely on insect control as a primary entry point into large-scale row-crop applications.

Fungicide is the second-largest segment, supported by the established use of microbial disease-control products in seed-stage protection programs. Products such as Koppert B.V.'s Cerall and Cedomon continue to support the adoption of biological control for seed-borne diseases in barley, oats, and related crops, keeping fungicidal biologicals closely aligned with integrated pest management practices. The other pesticides segment is forecast to register a 14.8% CAGR from 2026 through 2031 as suppliers expand into biochemical nematicides, biorepellents, and plant defense activators. This growth is supported by a regulatory environment increasingly favorable to lower-risk crop protection categories. Within the industry, this suggests the product mix will continue to diversify, even as insect control maintains its leading position.

The Commercial segment accounted for 58.0% of the EMEA biopesticides seed treatment market in 2025, reflecting strong reliance on professional seed treatment infrastructure. Large seed companies and conditioning facilities apply biological products with greater dosing accuracy, coating consistency, and handling reliability compared to farm-level operations. This operational advantage is important because biological seed treatments are more sensitive to application quality than conventional products. For this reason, commercial channels remain the most effective route for market scaling.

The Commercial segment is also forecast to grow at 13.9%, from 2026 through 2031, making it the fastest end-user profile, as suppliers prioritize environments with the strongest workflow control. Incotec B.V. (Croda International plc) work on microplastic-free coatings reflects a broader shift toward more advanced, regulation-ready processing systems in commercial treatment environments. Novonesis A/S also expanded its biosolutions distribution reach in 2026, covering seed treatment applications across major row and specialty crops, supporting the long-term development of formal commercial channels for biological products. Farm-level treatment remains relevant in parts of Africa where centralized treating infrastructure is less developed, but commercial processors remain the primary channel. Within the market, this pattern favors companies that can offer not only active ingredients, but also application reliability.

Complete Report Scope:

• By Product Type
  • Insecticide
  • Fungicide
  • Other Pesticides
• By End User
  • Commercial
  • Farm Level
• By Application Technique
  • Seed Coating
  • Seed Pelleting
  • Seed Dressing
  • Other Application Techniques
• By Crop Type
  • Grains and Cereals
  • Pulses and Oilseeds
  • Fruits and Vegetables
  • Other Crop Types
• By Geography
  • Europe
    • United Kingdom
    • Germany
    • Russia
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Middle East
    • Saudi Arabia
    • United Arab Emirates
    • Oman
    • Rest of Middle East
  • Africa
    • Egypt
    • Ethiopia
    • South Africa
    • Rest of Africa

List of Companies Covered in this Report:

1. Bayer AG
2. Syngenta AG
3. BASF SE
4. Corteva Agriscience
5. Novonesis A/S
6. Koppert Biological Systems B.V.
7. Certis Biologicals (Mitsui and Co., Ltd.)
8. Valent BioSciences LLC (Sumitomo Chemical Company, Limited)
9. Lallemand Inc.
10. Bioceres Crop Solutions Corp.
11. BioWorks, Inc.
12. Andermatt Biocontrol AG
13. Plant Health Care plc
14. Incotec B.V. (Croda International plc)
15. Seipasa S.A.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Demand for Low-Residue Crop Protection
  • 4.2.2 Expansion of Biologicals in Seed Coating Workflows
  • 4.2.3 Grower Adoption of Preventive, Early-Season Crop Protection
  • 4.2.4 Regulatory Pressure on Synthetic Seed Treatments
  • 4.2.5 Precision Seed Delivery and Micro-Dosing Compatibility
  • 4.2.6 Strain Stability and Seed-Handling Innovation
• 4.3 Market Restraints
  • 4.3.1 Variable Field Efficacy Across Soil and Climate Conditions
  • 4.3.2 Limited Shelf Life and Storage Sensitivity of Biologicals
  • 4.3.3 Higher Cost-to-Performance Perception Versus Conventional Chemicals
  • 4.3.4 Fragmented Registration and Seed Treatment Approval Complexity
• 4.4 Regulatory Landscape
• 4.5 Technological Outlook
• 4.6 Porter's Five Forces Analysis
  • 4.6.1 Bargaining Power of Suppliers
  • 4.6.2 Bargaining Power of Buyers
  • 4.6.3 Threat of New Entrants
  • 4.6.4 Threat of Substitutes
  • 4.6.5 Intensity of Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)

• 5.1 By Product Type
  • 5.1.1 Insecticide
  • 5.1.2 Fungicide
  • 5.1.3 Other Pesticides
• 5.2 By End User
  • 5.2.1 Commercial
  • 5.2.2 Farm Level
• 5.3 By Application Technique
  • 5.3.1 Seed Coating
  • 5.3.2 Seed Pelleting
  • 5.3.3 Seed Dressing
  • 5.3.4 Other Application Techniques
• 5.4 By Crop Type
  • 5.4.1 Grains and Cereals
  • 5.4.2 Pulses and Oilseeds
  • 5.4.3 Fruits and Vegetables
  • 5.4.4 Other Crop Types
• 5.5 By Geography
  • 5.5.1 Europe
    • 5.5.1.1 United Kingdom
    • 5.5.1.2 Germany
    • 5.5.1.3 Russia
    • 5.5.1.4 Spain
    • 5.5.1.5 Italy
    • 5.5.1.6 France
    • 5.5.1.7 Rest of Europe
  • 5.5.2 Middle East
    • 5.5.2.1 Saudi Arabia
    • 5.5.2.2 United Arab Emirates
    • 5.5.2.3 Oman
    • 5.5.2.4 Rest of Middle East
  • 5.5.3 Africa
    • 5.5.3.1 Egypt
    • 5.5.3.2 Ethiopia
    • 5.5.3.3 South Africa
    • 5.5.3.4 Rest of Africa

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Share Analysis
• 6.4 Company Profiles (Includes Global Level Overview, Market Level Overview, Core Segments, Financials as Available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.4.1 Bayer AG
  • 6.4.2 Syngenta AG
  • 6.4.3 BASF SE
  • 6.4.4 Corteva Agriscience
  • 6.4.5 Novonesis A/S
  • 6.4.6 Koppert Biological Systems B.V.
  • 6.4.7 Certis Biologicals (Mitsui and Co., Ltd.)
  • 6.4.8 Valent BioSciences LLC (Sumitomo Chemical Company, Limited)
  • 6.4.9 Lallemand Inc.
  • 6.4.10 Bioceres Crop Solutions Corp.
  • 6.4.11 BioWorks, Inc.
  • 6.4.12 Andermatt Biocontrol AG
  • 6.4.13 Plant Health Care plc
  • 6.4.14 Incotec B.V. (Croda International plc)
  • 6.4.15 Seipasa S.A.

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK